Search results
Showing 541 to 555 of 667 results for kidney or kidneys or renal
Source guidance details Comes from guidance Chronic kidney disease: assessment and management Number NG203 Date issued
This guideline covers optimising care for adults with multimorbidity (multiple long-term conditions) by reducing treatment burden (polypharmacy and multiple appointments) and unplanned care. It aims to improve quality of life by promoting shared decisions based on what is important to each person in terms of treatments, health priorities, lifestyle and goals. The guideline sets out which people are most likely to benefit from an approach to care that takes account of multimorbidity, how they can be identified and what the care involves.
Everolimus for the second-line treatment of advanced renal cell carcinoma (TA219)
This guidance has been updated and replaced by NICE technology appraisal guidance 432.
frequency bioimpedance devices to guide fluid management in people with chronic kidney disease having dialysis Number DG29 Date issued...
binders. Source guidance details Comes from guidance Chronic kidney disease: assessment and management Number NG203 Date issued
CKD. Source guidance details Comes from guidance Chronic kidney disease: assessment and management Number NG203 Date issued
but well-recognised safety concerns, including device failure and acute kidney injury. Evidence on efficacy is limited in quantity....
Evidence-based recommendations on cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for treating intermittent claudication in adults with peripheral arterial disease.
View recommendations for TA223Show all sections
Evidence-based recommendations on durvalumab (Imfinzi) with tremelimumab (Imjudo) for untreated advanced or unresectable hepatocellular carcinoma in adults.
Summary of the evidence on oral glycopyrronium bromide for severe sialorrhoea (drooling) in children and young people with chronic neurological disorders
CKD. Source guidance details Comes from guidance Chronic kidney disease: assessment and management Number NG203 Date issued
High-sensitivity troponin tests for the early rule out of NSTEMI (HTG552)
Evidence-based recommendations on high-sensitivity troponin tests for the early rule out of NSTEMI (non-ST-segment elevation myocardial infarction).
Evidence-based recommendations on the CoaguChek XS system for self-monitoring coagulation status in adults and children. The recommendations originally included the InRatio2 PT/INR, but this was withdrawn from the market in October 2016 and is not currently available.
Interventional procedures, IPG418 - Issued: January 2012 --> This guidance has been updated and replaced by NICE interventional procedures guidance 754.
Filgotinib for treating moderately to severely active ulcerative colitis (TA792)
Evidence-based recommendations on filgotinib (Jyseleca) for moderately to severely active ulcerative colitis in adults when conventional or biological treatment cannot be tolerated, or the disease has responded inadequately or lost response to treatment.